tbuckley/cabot-search huggingface dataset:
KENTUCKY STATE MEDICAL SOCIETY.
Journal: JAMA (1896)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Physician's Obligations to Insurance Company
Journal: JAMA (1967)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Applicability of liver transplantation (LT) in fulminant hepatic failure (FHF) SE Rojter, FG Villamil, LG Podesta, L Sher, A Hoffman, L Memsic, GM Woolf, AA Demetriou, L Makowka and JM Vierling. Hepatology and Liver Transplantation Programs, Cedars-Sinai Medical Center/UCLA, Los Angeles, CA
Journal: Hepatology (1994)
Chronic hepatitis C virus infection associated with a generalized granuloma annulare
Authors: Brigitte Granel a, Jacques Serratrice a, Jérôme Rey a, Cozinne Bouvier b, Claude Weiller-Merli a, Patrick Disdier a, Jean-François Pellissier b, Pierre-Jean Weiller a
Journal: Journal of the American Academy of Dermatology (2000)
Mikulicz' Disease of Palate
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
AN EASY METHOD FOR THE DISTINCTION AND ESTIMATION OF LACTOSE AND GLUCOSE IN URINE
Journal: JAMA (1920)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
National Asthma Education and Prevention Program Working Group Report on the Financing of Asthma Care
Authors: John Billings, Sandra E. Kretz, Robin Rose, Sara Rosenbaum, Myrtis Sullivan, Jinnet Fowles, Kevin B. Weiss
Journal: American Journal of Respiratory and Critical Care Medicine (1996)

The financing of asthma care is the third topic of the National Asthma Education and Prevention Program Task Force Report on the Cost Effectiveness, Quality of Care, and Financing of Asthma Care. This working group explored the effects of financing on access to services, treatment of asthma, and potential health outcomes. Over the course of a year, the working group collected and analyzed information pertaining to the various types of public and private health care financing mechanisms, including both insurance-based and non-insurance-based issues. The group examined the published literature and gathered information from four public hearings conducted across the nation. The result of this synthesis of information on health care financing and asthma care is a set of 12 recommendations that seek to improve the financing of asthma care.
The Delivery
Authors: Stewart L. Massad
Journal: JAMA (1997)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Reply to Dr Schrader and Dr Miller's Letter to the Editor re: Udo Nagele, Markus Kuczyk, Aristotelis G. Anastasiadis, Karl-Dietrich Sievert, Jörg Seibold, Arnulf Stenzl. Radical Cystectomy and Orthotopic Bladder Replacement in Females. Eur Urol 2006;50;249–257
Authors: Udo Nagele, Arnulf Stenzl
Journal: European Urology (2006)
Dermatological manifestations in the era of new direct acting antivirals: a single-center experience
Authors: Mohamed Talkhan, Khaled Raafat, Nouran Said, Ossama A Ahmed, Gina Naguib, Hany Dabous, Mohamed Kamal Shaker, Yehia Elshazly, Manal Hamdy El-Sayed, Mahira El Sayed
Journal: Journal of Hepatology (2020)
Correlation of Environmental Carbaryl Measurements with Serum and Urinary 1-Naphthol Measurements in a Farmer Applicator and His Family
Authors: Dana B. Shealy, John R. Barr, David L. Ashley, Donald G. Patterson, David E. Camann, Andrew E. Bond
Journal: Environmental Health Perspectives (1997)

In exposure or risk assessments, both environmental and biological measurements are often used. Environmental measurements are an excellent means for evaluating regulatory compliance, but the models used to estimate body burden from these measurements are complex. Unless all possible routes of exposure (i.e., inhalation, dermal absorption, ingestion) are evaluated, exposure to a toxicant can be underestimated. To circumvent this problem, measurements of the internal dose of a toxicant in blood, serum, urine, or tissues can be used singularly or in combination with environmental data for exposure assessment. In three separate laboratories, carbaryl or its primary metabolite, 1-naphthol, was measured in personal air, dermal samples, blood serum, and urine from farmer applicators and their families. The usefulness of both environmental and biological data has been demonstrated. For the farmer applicator, the environmental levels of carbaryl would have been sufficient to determine that an exposure had occurred. However, biological measurements were necessary to determine the absorbed dose of each member of the applicator's family. In addition, a correlation between serum and urinary 1-naphthol measurements has been shown; therefore, either matrix can be used to accurately evaluate occupational carbaryl exposure.
Ten Students Receive Research Fellowship Awards
Journal: JAMA (1965)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Current view of epidemiologic study designs for occupational and environmental lung diseases.
Authors: I B Tager
Journal: Environmental Health Perspectives (2000)

Epidemiologic studies long have played a role in the understanding of the effects of the general environment and various occupational exposures on the occurrence of acute and chronic diseases of the lung. This article is an overview of epidemiologic study designs that have particular relevance to studies of environmental and occupational lung disease. The application of times-series designs in the context of epidemiologic studies is discussed, as such designs have become widely used in studies of health effects ambient air pollution. The article emphasizes recent developments in the application of case-control study designs, many of which have had particular applications in epidemiologic studies related to environmental and occupational lung disease. These case-control designs offer efficient and valid alternatives for studies that in the past might have been conducted as more costly and time-consuming cohort studies.
BOOK REVIEWS
Authors: P. A. BURCH
Journal: JNCI Journal of the National Cancer Institute (1991)

BOOK REVIEWS Get access Neuro-Oncology: Primary Malignant Brain Tumors . David G. T. Thomas .ed. Baltimore, Md : The Johns Hopkins University Press , 1990 , 303 pp. $62.50. PATRICK A. BURCH PATRICK A. BURCH Division of Medical Oncology, Mayo Medical School200 First St, SW, Rochester, MN 55905. Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 83, Issue 4, 20 February 1991, Pages 294–295, https://doi.org/10.1093/jnci/83.4.294-a Published: 20 February 1991
Cytotoxic-induced ovarian failure in Hodgkin's disease. II. Effects on sexual function
Authors: R. M. Chapman
Journal: JAMA (1979)

Chemotherapy for Hodgkin's disease produces ovarian failure in young women. The consequences of this are emotional distress, sexual dysfunction, and the disruption of families and friendships. These previously unappreciated side effects of cytotoxic therapy had developed in 25 of 41 patients, among whom we conducted a retrospective study. (<i>JAMA</i>242:1882-1884, 1979)
Bath
Authors: Curtis R. Chong
Journal: JAMA Oncology (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Oncology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Oncology journal
Is the Incidence of Hypospadias Increasing? Analysis of Finnish Hospital Discharge Data 1970-1994
Authors: Martti Aho, Anna-Maija Koivisto, Teuvo L. J. Tammela, Anssi Auvinen
Journal: Environmental Health Perspectives (2000)

Reports suggesting an increasing incidence of male genitourinary anomalies such as hypospadias, possibly related to environmental factors such as environmental estrogen-like compounds, have recently received considerable publicity. These reports are based on birth defects registry data, and there may be variation in the completeness of the registries used. We analyzed temporal trends in the prevalence of hypospadias in Finland to assess the previously reported low overall prevalence and to detect any possible increasing tendencies during the past decade. We identified all patients who were surgically treated for hypospadias before the age of 9 years among boys born 1970-1986 in the national hospital discharge registry. We calculated the cumulative prevalence by dividing the number of patients by the number of male births, and we used Poisson regression analysis. Out of 549,176 boys born in Finland in 1970-1986, 1,543 were treated for hypospadias by the age of 8 years (28.1 surgically treated patients per 10,000 male live births; 95% confidence interval, 26.7-29.5). The prevalence of hypospadias in Finland remained constant throughout the study period and appears to have been approximately three times higher than previously reported. Changes in completeness of registration may account for a substantial proportion of the reported increases in the prevalence of hypospadias in Finland and possibly also elsewhere.
The death of Walter Reed
Authors: W. H. Crosby
Journal: JAMA (1982)

LAST year, in a military hospital in the Washington area, a house officer was rounding with four medical students. It was his daily custom to ask a cultural question. "Today," he said, "I'll give an A to the one who can tell me what Walter Reed died of." Brief silence. Then one of the students ventured, "Sir, I believe he died of peritonitis after an appendectomy." "Wrong," said the instructor, "He died of yellow fever." I told this story to a friend, senior in years and wise beyond those years. My story was interrupted at the house officer's question: "Yellow fever!" Yellow fever is not the answer. The student was correct, precisely correct. Walter Reed did die of peritonitis following an appendectomy. But his death remains a mystery. What ailed him and his appendix is not known. <h3>'I Am Dreadfully Melancholic'</h3> Walter Reed, Major, Medical Corps, US Army, died in
Capacity for stochastic self-renewal and differentiation in mammalian spermatogonial stem cells
Authors: Zhuoru Wu, Katherine Luby-Phelps, Abhijit Bugde, Laura A. Molyneux, Bray Denard, Wen-Hong Li, Gürol M. Süel, David L. Garbers
Journal: The Journal of Experimental Medicine (2009)
Hyponatremic Seizures Among Infants Fed With Commercial Bottled Drinking Water— Wisconsin, 1993
Journal: JAMA (1994)

In 1993, two infants were treated at a pediatric referral hospital in Wisconsin for hyponatremic seizures caused by water intoxication associated with bottled drinking water. This report summarizes information about these cases and a review of hospitalizations for hyponatremic seizures in this hospital during 1984-1993.
Editor Garland of The New England Journal
Authors: J. R. E.
Journal: Annals of Internal Medicine (1967)

Editorials1 July 1967Editor Garland of The New England JournalJ. R. E., E. J. H.J. R. E.Search for more papers by this author, E. J. H.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-67-1-207 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThis month, for the first time in 20 years, the masthead of The New England Journal of Medicine appears without the name of Joseph Garland as Editor. In its place is that of Franz J. Inglefinger who brings to his new post a wide experience as physician, teacher, an editor for The Year Book of Medicine, and former member of the Editorial Board of the journal he now directs. To Dr. Inglefinger we extend all good wishes for a succesful voyage over the editorial seas.The retirement of Dr. Garland marks the end of one of the most successful editorships...References1. Editorial: The content of a journal. New Eng. J. Med. 267: 674, 1962. CrossrefGoogle Scholar2. GARLAND J: The joys and rewards of an editor. Bull. Amer. Med. Writers' Ass. 12: 47, 1962. Google Scholar3. Editorial: Wordsmanship, no less. New Eng. J. Med. 263: 1261, 1960. CrossrefGoogle Scholar4. Editorial: The wearing of the genes. New Eng. J. Med. 258: 504, 1958. CrossrefGoogle Scholar5. Editorial: Proposed expedition to the Caledonian Canal. New Eng. J. Med. 262: 201, 1960. CrossrefGoogle Scholar6. Editorial: Operation beachhead. New Eng. J. Med. 274: 1443, 1966. Google Scholar7. Correspondence: Winter of our discontent. Ibid., p. 909. Google Scholar8. Correspondence: Lunar lungfish. Ibid., p. 1388. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 1 July 1967Volume 67, Issue 1Page: 207-209 Issue Published: 1 July 1967 PDF DownloadLoading ...
ACTR-23. MOLECULAR GENETIC, HOST-DERIVED AND CLINICAL DETERMINANTS OF LONG-TERM SURVIVAL IN GLIOBLASTOMA: FIRST RESULTS FROM THE BRAIN TUMOR FUNDERS’ COLLABORATIVE CONSORTIUM
Authors: Caroline Happold, Jörg Felsberg, Jennifer Clarke, Riccardo Soffietti, Christine Marosi, Dietmar Krex, François Ducray, Peter Hau, Jaap Reijneveld, Astrid Weyerbrock, Antje Wick, David Reardon, Martin Glas, Evangelia Razis, Ulrich Herrlinger, Joerg-Christian Tonn, Antoine F Carpentier, Florence Lefranc, Emilie Le Rhun, Tina Verschuere, Vassilis Golfinopoulos, Martin Klein, Guido Reifenberger, Michael Weller
Journal: Neuro-Oncology (2017)

Survival in glioblastoma patients is usually in the range of 12–15 months, and less than 5% of patients survive 5 years from diagnosis. Little is known about factors influencing long-term survival. A consortium generously funded by the Brain Tumor Funders’ Collaborative comprising more than 20 clinical sites in Europe, the US, and Australia registers patients with glioblastoma who survived for at least 5 years. The aim of the study is a better understanding of factors contributing to prolonged survival by assessment of (i) clinical features, (ii) molecular parameters, (iii) therapy and quality of life-related factors, and (iv) immunological parameters. The histopathological diagnosis of glioblastoma is centrally reviewed at study entry. Clinical characteristics including imaging data are collected at the European Organisation for Research and Treatment of Cancer (EORTC) in Brussels, Belgium. Comprehensive molecular analyses are performed at the German Cancer Research Center (DKFZ), Germany. Immunological parameters are analyzed in Zurich, Switzerland. Alive patients are followed by neurocognitive assessments additionally. At the cut-off of May 30, 2017, 182 patients have been registered by 17 sites; 107 patients are alive, more than half of which contribute to the neurocognitive assessments and patient-related outcome studies, as well as the immunological studies. First comprehensive results of disease characteristics with a cut-off of September 30, 2017, will be presented. The collaborative effort of this consortium by comprehensive characterization of molecular parameters, immunological aspects, and individual clinical and therapy-related determinants will contribute to a better understanding of factors that modulate the course of this disease.